Central nervous system (CNS) disorders affect as many as 1.5 billion people globally. The
limited delivery of most imaging and therapeutic agents into the brain is a major challenge …

The advent of nanotechnology has led to an increased interest in nanocarriers as a drug
delivery system that is efficient and safe. There have been many studies addressing nano …

The buildup of nonionic surfactants in the aqueous environment produces niosomes. The
usage of niosomes is becoming increasingly frequent due to their sustainability, low cost of …

In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

Chemotherapy is widely used for cancer therapy; however, its efficacy is limited due to poor
targeting specificity and severe side effects. Currently, the next generations of delivery …

The early-stage diagnosis and therapy of brain diseases pose a persistent challenge in the
field of biomedicine. Quantum dots (QDs), nano-luminescent materials known for their small …

Glioblastoma multiforme (GBM) is the most common and lethal type of brain tumor, and the
clinically available approaches for its treatment are not curative. Despite the intensive …

Introduction Targeted delivery of drugs to the brain is a complicated activity. This
complication is caused by the blood–brain barrier (BBB). Interestingly, there are various …

Magnetic resonance imaging (MRI) holds promise for the early clinical diagnosis of various
diseases, but most clinical MR techniques require the use of a contrast medium. Several …

Introduction: In recent years, various nanoparticles (NPs) have been discovered and
synthesized for the targeted therapy of cancer cells. Targeted delivery increases the local …